Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

95.17 -0.67 (-0.70%)

Streaming Delayed Price Updated: 1:46 PM EDT, Jul 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9

...

56 57 Next >

Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q3 Earnings?

December 31, 2025

Over the past six months, Abbott Laboratories’s shares (currently trading at $125.45) have posted a disappointing 7.9% loss, well below the S&P 500’s 11.2% gain. This may have investors wondering how...

Via StockStory

Topics Stocks Supply Chain

Is Fidelity Medical Equipment the Ultimate "Forever Fund" for Health Care Investors? ↗

December 24, 2025

This basket of 64 medical device stocks could raise its dividend for decades.

Via The Motley Fool

Topics ETFs Government Supply Chain

Broadcom Just Raised Its Dividend—But It’s Not the Only One Signaling Strength ↗

December 22, 2025

Via MarketBeat

2 Dividend Stocks to Buy for 2026 and Beyond ↗

December 18, 2025

The healthcare sector is a great place to find quality income stocks, and these two appear to be strong picks.

Via The Motley Fool

Exact Sciences Stock Soars To 4-Year High Even As Wall Street Piles On Downgrades After Abbott Deal — Retail Traders Take Profits ↗

November 20, 2025

Via Stocktwits

Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover ↗

November 20, 2025

Via Stocktwits

1 Safe-and-Steady Stock to Consider Right Now and 2 We Turn Down

December 16, 2025

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

Stay informed with the top movers within the S&P500 index on Monday. ↗

December 15, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Start the New Year Off With Passive Income: 3 Dividend Kings to Buy Now ↗

December 14, 2025

These stocks will pay you just for owning them.

Via The Motley Fool

My Top 10 Stocks to Buy for 2026 ↗

December 13, 2025

These players are well-positioned to potentially gain next year -- and over time.

Via The Motley Fool

Topics Artificial Intelligence

Abbott Laboratories (NYSE:ABT) Offers a Dependable Dividend Backed by Strong Fundamentals ↗

December 10, 2025

Abbott Laboratories (ABT) is a top dividend stock with a strong history of increases, backed by exceptional earnings power and a very healthy balance sheet for reliable income.

Via Chartmill

Danaher Sweetens the Pot: Board Approves $0.32 Quarterly Cash Dividend, Signaling Robust Financial Health

December 09, 2025

New York, NY – December 9, 2025 – Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that its Board of Directors has approved a regular quarterly cash dividend...

Via MarketMinute

2 Mega-Cap Stocks with Promising Prospects and 1 Facing Challenges

December 07, 2025

"Too big to fail" is how we would describe the megacap stocks in this article today. While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their...

Via StockStory

Here's Why Grail Soared, Again, in November ↗

December 02, 2025

A combination of operational improvements and developments at its key rival bolstered the stock recently.

Via The Motley Fool

This Top Dividend King Just Became an Even Better Buy ↗

November 30, 2025

The healthcare leader wants to make waves in a potentially highly lucrative market.

Via The Motley Fool

Synlait Milk Trims 2025/2026 Milk Price Forecast Amidst Global Commodity Headwinds

November 26, 2025

New Zealand's Synlait Milk (NZX: SML) has announced a reduction in its annual base milk price forecast for the 2025/2026 season, signaling persistent challenges within the global dairy commodity...

Via MarketMinute

Topics Economy Emissions Supply Chain

AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy Government World Trade

Top 2 Healthcare Stocks Every New Investor Should Know ↗

November 21, 2025

These healthcare stocks have long-term and profitable growth runways.

Via The Motley Fool

2 Fantastic Dividend Stocks to Buy and Hold Forever ↗

November 21, 2025

These companies have been raising their payouts for a combined 101 consecutive years.

Via The Motley Fool

Topics Intellectual Property

Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More ↗

November 20, 2025

On a big day for tech stocks, some other less well-known companies saw even larger moves.

Via The Motley Fool

Topics Artificial Intelligence Stocks

Why Exact Sciences Rallied Over 50% This Week ↗

November 20, 2025

The company received a buyout offer from Abbot Labs.

Via The Motley Fool

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Exact Sciences Corporation (Nasdaq – EXAS)

November 20, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Why Exact Sciences Stock Surged Today ↗

November 20, 2025

A healthcare giant covets the cancer screening leader's technology.

Via The Motley Fool

UBS Raises Medtronic Target Price Amid Strong Q2, PFA Technology Shines, But "Neutral" Stance Lingers

November 20, 2025

New York, NY – November 20, 2025 – UBS Group has adjusted its outlook on Medtronic plc (NYSE: MDT) stock, raising its price target to $102.00 from $95.00. This upward revision follows Medtronic's...

Via MarketMinute

Topics Artificial Intelligence Economy

These S&P500 stocks are gapping in today's session ↗

November 20, 2025

Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Thursday. Discover the gap up and gap down stocks in the S&P500 index.

Via Chartmill

Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics ↗

November 20, 2025

Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highlight growth and valuation momentum.

Via Benzinga

Abbott To Acquire Exact Sciences For Up To $23B ↗

November 20, 2025

Under the deal, Exact Sciences shareholders will receive $105 per common share in cash.

Via Stocktwits

Why Exact Sciences Stock Blasted Nearly 24% Higher Today ↗

November 19, 2025

A strategic investor is reportedly in advanced talks to purchase the company.

Via The Motley Fool

2 Healthcare Stocks Worth Your Attention and 1 We Ignore

November 19, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and...

Via StockStory

Topics Stocks

2 Sweet Dividend Stocks to Buy to Satisfy Your Craving for Passive Income ↗

November 15, 2025

Dividend stocks can strengthen your portfolio during any market environment.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

56 57 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.